1. A user interface embodied on at least one computer-readable storage medium, the user interface comprising at least one display region for presenting:
a graphical representation simultaneously displaying two or more options for an administration schedule associated with a clinical order, each option including a set of display objects presented in a context to indicate administration dates of a substance-based orderable under each respective option, administration times of the substance-based orderable, the amount of time the substance-based orderable is supposed to be present within the body of a patient, and a maximum duration of exposing a patient to the substance-based orderable based on the amount of time the substance-based orderable is supposed to be present within the body of the patient,
wherein the clinical order has a first administration schedule associated therewith, and wherein the two or more options comprise corrective alternative scheduling for medication administration under the clinical order when the medication has been improperly given so as to stop a propagation of errors, each option being associated with a policy comprising one of:
maintaining the remaining number of doses of the substance-based orderable to be administered under the first administration schedule associated with the clinical order;
maintaining the remaining number of doses of the substance-based orderable to be administered under the first administration schedule associated with the clinical order while modifying a stop date and time for administration of the substance-based orderable that is as close as possible to a first stop date and time under the first administration schedule associated with the clinical order; and
modifying a stop date and time for administration of the substance-based orderable that represents temporal proximity with a first stop date and time under the first administration schedule associated with the clinical order.
2. The user interface of claim 1, wherein the two or more options further comprise the first administration schedule.
3. The user interface of claim 2, further comprising:
a textual representation of the policy associated with each of the two or more options; and
an option selection area associated with each textual representation for accepting input regarding a user selection of one option of the two or more options.
4. The user interface of claim 1, further comprising:
a dosage time selection area for accepting input utilized to generate the two or more options for an administration schedule, wherein the input is representative of one or more of:
an earliest time for administering a dose and a number of doses per day of the substance-based orderable for the administration schedule; and
a set of times representing when a dose of the substance-based orderable is to be administered within a day for the administration schedule.
5. A user interface embodied on at least one computer-readable storage medium, the user interface comprising at least one display region for presenting:
a graphical representation simultaneously displaying two or more options for an administration schedule associated with a clinical order, each option including a set of display objects presented in a context to indicate administration dates, administration times, and the amount of time a chemotherapy agent orderable is supposed to be present within the body of a patient under the respective option,
wherein the clinical order has a current administration schedule associated therewith, and wherein the two or more options comprise corrective alternative scheduling for medication administration under the clinical order when the medication has been improperly given so as to stop a propagation of errors, each option being associated with a policy comprising one of:
maintaining the remaining number of doses of the chemotherapy agent orderable to be administered under the first administration schedule associated with the clinical order;
maintaining the remaining number of doses of the chemotherapy agent orderable to be administered under the first administration schedule associated with the clinical order while modifying a stop date and time for administration of the substance-based orderable that is as close as possible to a first stop date and time under the first administration schedule associated with the clinical order; and
modifying a stop date and time for administration of the chemotherapy agent orderable that represents temporal proximity with a first stop date and time under the chemotherapy agent administration schedule associated with the clinical order.
6. The user interface of claim 5, wherein the two or more options further comprise the first administration schedule.
7. The user interface of claim 5, further comprising:
a textual representation of the policy associated with each of the two or more options; and
an option selection area associated with each textual representation for accepting input regarding a user selection of one option of the two or more options.
8. The user interface of claim 5, further comprising:
a dosage time selection area for accepting input utilized to generate the two or more options for an administration schedule, wherein the input is representative of one or more of:
an earliest time for administering a dose and a number of doses per day of the chemotherapy agent orderable for the administration schedule; and
a set of times representing when a dose of the chemotherapy agent orderable is to be administered within a day for the administration schedule.
9. A user interface embodied on at least one computer-readable storage medium, the user interface comprising at least one display region for presenting:
a graphical representation simultaneously displaying two or more options for an administration schedule associated with a clinical order, each option including a set of display objects presented in a context to indicate administration dates of a substance-based orderable under each respective option, administration times of the substance-based orderable, the amount of time the substance-based orderable is supposed to be present within the body of a patient, and a maximum duration of exposing a patient to the substance-based orderable based on the amount of time the substance-based orderable is supposed to be present within the body of the patient, wherein the two or more options comprise corrective alternative scheduling for medication administration under the clinical order when the medication has been improperly given so as to stop a propagation of errors, each option being associated with a policy comprising one of:
maintaining the remaining number of doses of the substance-based orderable to be administered under the first administration schedule associated with the clinical order;
maintaining the remaining number of doses of the substance-based orderable to be administered under the first administration schedule associated with the clinical order while modifying a stop date and time for administration of the substance-based orderable that is as close as possible to a first stop date and time under the first administration schedule associated with the clinical order; and
modifying a stop date and time for administration of the substance-based orderable that represents temporal proximity with a first stop date and time under the first administration schedule associated with the clinical order.
10. The user interface of claim 9, wherein the two or more options further comprise the first administration schedule.
11. The user interface of claim 9, further comprising:
a textual representation of the policy associated with each of the two or more options; and
an option selection area associated with each textual representation for accepting input regarding a user selection of one option of the two or more options.
12. The user interface of claim 9, further comprising:
a dosage time selection area for accepting input utilized to generate the two or more options for an administration schedule, wherein the input is representative of one or more of:
an earliest time for administering a dose and a number of doses per day of the substance-based orderable for the administration schedule; and
a set of times representing when a dose of the substance-based orderable is to be administered within a day for the administration schedule.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A semiconductor memory device comprising:
a first mat having a plurality of first memory cells; and
a second mat having a plurality of second memory cells,
wherein the first and second mats are formed in a single well region.
2. The semiconductor memory device of claim 1, wherein:
the first and second mats share a first well disposed in the single well region,
the first well comprises a first conductivity type,
the first well is formed in a second well disposed in the single well region,
the second well comprises a second conductivity type, and
the second well is formed in a semiconductor substrate of the first conductivity type.
3. The semiconductor memory device of claim 2, wherein the first and second wells and the semiconductor substrate are biased independently of each other.
4. The semiconductor memory device of claim 2, wherein the first and second conductivity types are opposite to each other.
5. The semiconductor memory device of claim 2, wherein the first well comprises a pocket P-well (PP-well) having at least one impurity region formed therein.
6. The semiconductor memory device of claim 5, wherein:
the first mat comprises first memory cells having first floating and control gates formed over the at least one impurity region formed in the PP-well,
the second mat comprises second memory cells having second floating and control gates formed over the at least one impurity region formed in the PP-well, and
the first memory cells are controlled independently of the second memory cells.
7. The semiconductor memory device of claim 1, wherein the first and second mats are controlled independently by peripheral circuits.
8. The semiconductor memory device of claim 7, wherein the peripheral circuits are row selectors.
9. The semiconductor memory device of claim 8, wherein each of the row selectors is disposed at the middle of one of the first and second mats.
10. The semiconductor memory device of claim 8, wherein each of the row selectors is disposed at one side of the first and second mats, respectively.
11. The semiconductor memory device of claim 1, wherein the first and second mats are arranged in one of row and column directions.
12. The semiconductor memory device of claim 1, wherein the first and second mats are substantially the same in structure.
13. The semiconductor memory device of claim 1, wherein the memory cells are flash memory cells.
14. The semiconductor memory device of claim 13, wherein the flash memory cells are configured in one of NAND and NOR structures.
15. A semiconductor memory device comprising:
at least four mats structured and arranged in columns and rows;
a plurality of row selectors, each row selector corresponding to one of the at least four mats and disposed at one side of the at least four mats, respectively;
a plurality of page buffers disposed orthogonally to one of the row selectors and disposed at another side of the at least four mats different from the sides having disposed thereat the row selectors;
a plurality of column selectors, each column selector coupled to one of the page buffers,
wherein each row selector corresponds to one of the at least four mats, each page buffer corresponds to one of the at least four mats, each column selector corresponds to one of the at least four mats, and wherein the at least four mats are formed in a single well region.
16. The semiconductor memory device of claim 15, wherein:
the at least four mats share a first well disposed in the single well region,
the first well comprises a first conductivity type,
the first well is formed in a second well disposed in the single well region,
the second well comprises a second conductivity type, and
the second well is formed in a semiconductor substrate of the first conductivity type.
17. The semiconductor memory device of claim 16, wherein:
the first well comprises a pocket P-well (PP-well) having at least one impurity region formed therein,
each of the at least four mats comprise memory cells having first floating and control gates formed over the at least one impurity region formed in the PP-well, and
the memory cells of one of the at least four mats are controlled independently of memory cells of another of the at least four mats.
18. The semiconductor memory device of claim 15, wherein the row selectors and the column selectors are independently controlled, and wherein the at least four mats are independently controlled by the independently controlled row selectors and the column selectors.
19. A memory card comprising:
a semiconductor memory device; and
a controller configured to control the semiconductor memory device,
wherein the semiconductor memory device comprises:
a first mat having a plurality of first memory cells; and
a second mat having a plurality of second memory cells,
wherein the first and second mats are formed in a single well region.
20. The memory card of claim 19, wherein:
the first and second mats share a first well disposed in the single well region,
the first well comprises a first conductivity type,
the first well is formed in a second well disposed in the single well region,
the second well comprises a second conductivity type, and
the second well is formed in a semiconductor substrate of the first conductivity type.